1Eroglu A,Demirci A,Ayyildiz A,et al.Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patents with gastric cancer[].British Journal of Cancer.1999
2Inaba K,Inaba M,Romani N,et al.Generation of large numbers of dendritic cells from mouse bone marrow culture supplemented with granulocyte/macrophage colony-stimulating factor[].The Journal of Experimental Medicine.1992
3Guidoboni M,Doglioni C,Laurino L.Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas.Differences between high-grade and low-grade cases[].American Journal of Pathology.1999
4Saito H,Tsujitani S,Ikeguchi M,et al.Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue[].J Immunology.1999
5Maeda K,Chung YS,Ogawa Y,et al.Prognostic value of vascular endothelial growth factor expression in gastric cancer[].Cancer.1999
6Thurner B,Haendle I,Roder C,et al.Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma[].The Journal of Experimental Medicine.1999
2Rong-Fu W. Functional control of regulatory T cells and cancer immunotherapy[J] Seminars in Cancer Biology,2006,16 : 106-114.
3Dunn GP,Old LJ,Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol,2004,22 : 329-360.
4Tirapu I ,Calvillo M ,Qian C ,et al. Cytokine gene transfer into dendritic cells for cancer treatment. Curr C, ene Ther,2002 ,2 :79-89.
5Kayagaki N, Yamaguchi N, Nakayama M, et al. Expression and function of TNF2related apoptosis2 inducing ligand on murine activated NK cells. J Immunol, 1999,163 : 1906-1913.
6Screpanti V,Wallin RP,Ljunggren HG,et al. A central role for death receptor mediated apoptosis in the rejection of tumors by NK cells. J Immunol,2001,167 :2068-2073.
7Yang ZZ, Novak AJ,Ziesmer CS, et al. Attenuation of CD8 ( + ) T-cell function by CD4 ( + ) CD25 ( + ) regulatory T cells in B-cell non- Hodgkin ' s lymphoma. Cancer Res ,2006,66 : 10145-10152.
8Fukuiwa T, Sekine S, Kobayashi R, et al. A combination of Flt3 ligand cDNA and CpGODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immuni- ty. Vaccine ,2008,26:4849-4859.
9Frank ON, Selma A, Michel G, et al. Vaccination of melanona patients with pepitide-or tumor lysate pulsed dendritic cells. Nat Med,1998, 4: 328.
